Posted on 9/4/18
Cognate BioServices and FloDesign Sonics Announce Collaboration
FloDesign Sonics, a global leader in acoustic cell processing for cell and gene therapies, and Cognate BioServices, a leading contract development and manufacturing organization in the . . .
Posted on 9/4/18
Cronos Group and Ginkgo Bioworks Announce a Landmark Partnership
Today, Cronos Group Inc. (NASDAQ:CRON) (TSX: CRON), a geographically diversified and vertically integrated cannabis group, and Ginkgo Bioworks Inc., the organism company, announced a landmark partnership . . .
Posted on 9/4/18
CVS Health Offering Free Wellness Screenings in Rhode Island
In its continuing commitment to improve access to affordable health care for all Americans, CVS Health [NYSE: CVS] is expanding its annual Project Health campaign to . . .
Posted on 9/4/18
Otsuka Pharmaceutical Completes Acquisition of Visterra
Visterra, Inc. (Visterra) announces that Otsuka Pharmaceutical Co., Ltd. of Japan has completed the acquisition of Visterra for approximately USD 430 million
Posted on 9/4/18
89 Degrees Expands Loyalty Practice
BURLINGTON, Mass.--(BUSINESS WIRE)--Marketing service provider 89 Degrees is ramping up its loyalty team, the company’s largest and fastest growing practice area, with key new hires. 89 . . .
Posted on 9/4/18
Cigna Appoints Gina Papus as Global Chief Data and Analytics Officer
Global health service company Cigna (NYSE: CI) has appointed Gina Papush as Global Chief Data and Analytics Officer.
Posted on 9/4/18
Macrolide Pharmaceuticals Expands Leadership and Strengthens Expertise in Drug Development, Clinical Strategy, Finance and Business Development
WATERTOWN, Mass.--(BUSINESS WIRE)--Macrolide Pharmaceuticals, which is currently developing novel therapies to fight serious infections, today announced a leadership expansion that adds significant expertise in drug development, . . .
Posted on 9/4/18
Belmont Instrument Acquires HC LIFE
Belmont Instrument, LLC announced that it has acquired HC LIFE Ltd.. HC LIFE, headquartered in Wokingham, United Kingdom
Posted on 9/4/18
Vertex Pharmaceuticals Is A Solid Buy In 2018
SummaryVertex Pharmaceuticals continues to be a leading player in the cystic fibrosis space in 2018.The company is focused on advancing its research pipeline in the CF . . .
Posted on 9/4/18
Alzheon Files Revised IPO Statement For $40 Million
SummaryAlzheon aims to raise $40 million in an IPO of its common stock.The firm is developing a treatment candidate for Alzheimer's Disease.ALZH previously attempted to raise . . .
Posted on 9/14/18
Dominion Diagnostics Employees Observe International Overdose Awareness Day
Rhode Island-based medical laboratory Dominion Diagnostics joined thousands of other organizations and individuals across the globe to commemorate International Overdose Awareness Day during an event held . . .
Posted on 9/3/18
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., Aug. 31, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine . . .
Posted on 8/31/18
Bioasis Announces Stock Option Grants
GUILFORD, Conn.--(BUSINESS WIRE)--BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI), a biopharmaceutical company developing its xB3 TM proprietary platform technology for the delivery of therapeutics across the blood-brain barrier . . .
Posted on 8/30/18
Poxel Expands Metabolic Pipeline Through Strategic Acquisition Agreement with DeuteRx for DRX-065
LYON, France, & ANDOVER, Mass.--(BUSINESS WIRE)--POXEL SA, a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes and non-alcoholic . . .
Posted on 8/30/18
Vertex and Genomics plc Establish Collaboration
BOSTON & OXFORD, United Kingdom--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Genomics plc today announced a three-year collaboration, extendable to five years, to use human genetics . . .
Posted on 8/30/18
RootPath Raises $7 Million Seed Round
RootPath, a Cambridge-based biotechnology company developing a powerful personalized T cell therapy platform that bridges precision medicine and cancer immunotherapy
Posted on 8/29/18
Alliance HealthCare Radiology Finalizes Partnership with Northeast Radiology
IRVINE, Calif.--(BUSINESS WIRE)--Alliance HealthCare Services, Inc. today announces our partnership with Northeast Radiology and welcomes Northeast Radiology into its Alliance HealthCare Radiology division. A national leader . . .
Posted on 8/29/18
Nation’s Health CISOs Take Lead to Manage Third-Party Risk
BOSTON--(BUSINESS WIRE)--Prominent Chief Information Security Officers (CISOs) from leading health systems and providers throughout the country have come together to establish the Provider Third Party Risk . . .
Posted on 8/29/18
Immunomic Therapeutics CEO to Present at Immuno-Oncology Summit
BOSTON--(BUSINESS WIRE)--Tomorrow, Dr. Bill Hearl, Ph.D., Chief Executive Officer (CEO) of Immunomic Therapeutics, Inc. will present at the Immuno-Oncology Summit in Boston, Massachusetts. The presentation, “Addressing . . .
Posted on 8/29/18
Arch Therapeutics to Provide Corporate Update
FRAMINGHAM, Mass., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and . . .
Posted on 8/28/18
InfoBionic Signs BIOTRONIK as Exclusive U.S. Distributor for MoMe Kardia
BOSTON--(BUSINESS WIRE)--InfoBionic, a digital health company focused on creating next-generation solutions for ambulatory, cardiac arrhythmia monitoring, today announced an exclusive, strategic agreement with medical device manufacturer . . .
Posted on 8/28/18
Biotech Analysis Central Pharma News: J&J And Bayer Failure, Gilead Sciences Unloads Cancer Drug, Mallinckrodt Fails To Get Green Light
SummaryJ&J and Bayer fail to improve prospects for blood clot drug after trial results.Gilead Sciences offloads late-stage drug for myelofibrosis.Mallinckrodt suffers huge blow as FDA rejects . . .
Posted on 8/27/18
Provant Health Enters into Asset Purchase Agreement with Summit Health Subsidiary of Quest Diagnostics
EAST GREENWICH, R.I.--(BUSINESS WIRE)--Hooper Holmes, Inc. d/b/a Provant Health (OTCQX:HPHW), the largest publicly traded, pure-play health and well-being provider in the U.S., today announced that it . . .
Posted on 8/27/18
Akcea and Ionis Receive Complete Response Letter for WAYLIVRA from FDA
CAMBRIDGE, Mass. and CARLSBAD, Calif., Aug. 27, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ:AKCA) an affiliate of Ionis Pharmaceuticals, Inc., and Ionis Pharmaceuticals, Inc. (NASDAQ:IONS), . . .
Posted on 8/27/18
The Campbell Foundation Awards Grant to Advance Development of HIV Vaccine
The Campbell Foundation has awarded James Munro, PhD, of Tufts University School of Medicine in Boston, an $88,000 grant to address some key questions that grew . . .

